Biotricity Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2016	2015	2014
Net Income	-19.53	-30.22	-16.45	-11.32	-8.59	-8.62	-7.81	-7.28	-5.19	-1.71
Depreciation & Amortization	0.35	0.09	0	0	0	0	0	0	0	0.01
Share-Based Compensation	0.65	0.91	0.79	2.41	1.45	1	0.63	0.41	2.26	0
Other Operating Activities	4.12	12.96	3.62	0.8	1.92	2.75	3.43	4.49	0.96	0.32
Operating Cash Flow	-13.55	-15.16	-11.08	-7.86	-5.22	-4.87	-3.75	-2.38	-1.96	-1.38
Capital Expenditures	0	-0.03	0	0	0	0	0	0	0	0
Investing Cash Flow	0	-0.03	0	0	0	0	0	0	0	0
Share Issuance / Repurchase	0	14.8	0	0.03	3.69	5.29	1.34	0.11	0.71	1.72
Debt Issued / Paid	3.83	10.6	12.54	1.2	0.87	0	2.46	2.07	1.29	0
Other Financing Activities	-1.83	-0.22	-0.34	7.65	-	-	0.17	-	-	-
Financing Cash Flow	2	25.17	12.2	8.88	4.56	5.29	3.97	2.18	2	1.72
Exchange Rate Effect	0.05	-0.11	0.13	-0.13	-0.12	0	0.15	-0.19	-0.07	-0
Net Cash Flow	-11.55	9.98	1.12	1.02	-0.66	0.41	0.22	-0.2	0.03	0.33
Free Cash Flow	-13.55	-15.19	-11.08	-7.86	-5.22	-4.87	-3.75	-2.38	-1.96	-1.38
Free Cash Flow Margin	-140.55%	-198.60%	-327.37%	-554.61%	-1311.11%	-	-	-	-	-
Free Cash Flow Per Share	-1.56	-2.01	-1.77	-1.31	-0.94	-0.97	-0.87	-0.55	-0.54	-0.57

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).